The linguistic signature of hallucinated voice talk in schizophrenia.

Very few studies have investigated the formal linguistic aspects of auditory verbal hallucinations (AVHs), though speech is a defining aspect of AVHs. Hallucinated speech heard by 19 patients with schizophrenia and highly frequent voices was obtained online, as and when they spoke, and annotated for pre-selected linguistic variables. Results showed that, consistently across the sample, (i) the grammatical first Person was significantly less represented than both second and third person, and often absent altogether; (ii) overwhelmingly, isolated clauses with no grammatical connectivity (parataxis) were produced, as compared with subordinations, coordinations, and adjunctions; (iii) in all participants except one, virtually no noun phrases (NPs) were anaphoric ones, back-referring to previous NPs, illustrating again a lack of connectivity across utterances. (vi) Sentence-level content was largely personal rather than impersonal, and in impersonal utterances, it was generally vague. (v) Formal syntactic errors were consistently nearly absent, as were semantic level errors such as paraphasias. Voice talk was not generally stereotyped. These results indicate that, despite a certain amount of individual variation, there is a distinctive linguistic profile to voice speech, which constrains theories of AVHs and their neurocognitive basis.

Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

INTRODUCTION: The purpose of this study was to investigate whether single-voxel (SV) proton magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI), and diffusion tensor imaging (DTI) detected differences between fibromyalgia (FM) patients and healthy controls. We also searched for correlations between neuroimaging abnormalities and neuropsychological variables. METHODS: Ten patients with FM and 10 gender- and age-matched control subjects were studied. A neuropsychological examination, DWI, DTI, and proton MRS were performed on the brain areas known to be associated with pain processing. RESULTS: Compared with healthy controls, FM patients had significantly higher levels of glutamate + glutamine (Glx) (mean ± SD, 10.71 ± 0.50 arbitrary institutional units versus 9.89 ± 1.04; P = 0.049) and higher glutamate + glutamine/creatine (Glx/Cr) ratios (1.90 ± 0.12 versus 1.72 ± 0.23; P = 0.034) in the posterior gyrus. Myoinositol (Ins) levels of the right and left hippocampi were significantly lower in FM patients (4.49 ± 0.74 versus 5.17 ± 0.62; P = 0.008 and 4.91 ± 0.85 versus 6.09 ± 0.78; P = 0.004, respectively). In FM patients, decreased myoinositol/creatine (Ins/Cr) ratios were found in the left sensorimotor area (P = 0.05) and the left hippocampus (P = 0.002) and lower levels of choline (P = 0.019) and N-acetyl aspartate + N-acetyl aspartyl glutamate (NAA + NAG) (P = 0.034) in the left hippocampus. Significant correlations between depression, pain, and global function and the posterior gyrus Glx levels and Glx/Cr ratios were observed. CONCLUSIONS: Glx within the posterior gyrus could be a pathologic factor in FM. Hippocampal dysfunction may be partially responsible for the depressive symptoms of FM. Additional studies with larger samples are required to confirm these preliminary data.